Exercise training improves blood pressure, glucose control, lipid profile, exercise endurance, and objective measures of ischaemia. In addition, exercise training may lead to changes in weight and a sense of well-being. For these reasons, a regular exercise program should be part of a multifactorial intervention program in patients with stable chronic ischaemic heart disease.

Patients who are successfully treated for chronic ischaemic heart disease should have follow-up evaluation every 4 to 12 months. A more precise interval cannot be recommended because many factors influence the length of follow-up period. Five questions must be answered regularly during the follow-up evaluation:
(1) Has the patient decreased the level of physical activity?
(2) Have the patient’s anginal symptoms increased in frequency and become more severe since the last visit?
(3) How well is the patient tolerating therapy?
(4) How successful has the patient been in reducing modifiable risk factors and improving knowledge about ischaemic heart disease?
(5) Has the patient developed any new comorbid illnesses or has the severity or treatment of known comorbid illnesses worsened the patient’s angina?
Patients who cannot reliably identify and report changes in their status or who need more support with their treatment or risk factor reduction should be seen more frequently.

The increase globalization and modernization in life style of people has attributed many diseases. According to an survey of an death rate the “1” in every “4” death is among from an Ischemic heart diseases. Ischemic heart diseases are one of the most threatening problem faced by the people. The group of patients who are suffering from coronary arteries diseases  are very likely to be more prone to have developed with hypertension, life style  and not proper Diet. A ischemic heart disease is cure fast when we do proper diagnosis and take an suitable drug. Ischemic heart disease is cure when an patient change the lifestyle. And also is cure by taking proper diet and doing regular exercise , an avoiding the alcohol and smoking and taking suitable drug. If any symptoms acquire regarding coronary heart disease, it should fast consult doctor and diagnosis. By using these proper medicine and obey an prevention, we can reduce the sudden ischemic heart disease death and save the patient’s health & life.

1.  "Coronary heart disease".  NIH . Archived from the original on 12 September 2013. Retrieved 15 September 2013
2.  "Nitroglycerin Sublingual: MedlinePlus Drug Information". Archived from the original on 6 January 2017
3.  "WHO Disease and injury country estimates". World Health Organization. 2009. Archived from the original on 11 November 2009. Retrieved 11 November 2009
4.  Ambrose, John; Singh, Manmeet (2015). "Path physiology of coronary artery disease leading to acute coronary syndromes".  
5.  American College of Cardiology (September 2013), "Five Things Physicians and Patients Should Question", Choosing Wisely: an initiative of the ABIM Foundation, American College of Cardiology, archived from the original on 17 December 2013, retrieved 10 February 2014
6.  Erling Falk,Prediamn K. shah, Pim J. Feyter. Ischemic heart disease 1th edition. Burden on ischemic heart diseases. Page no-15 -18
7.  Erling Falk,Prediamn K. shah, Pim J. Feyter. Ischemic heart disease 1th edition. Anatomy of Heart. Page no: 20 to 23
8.  Hackshaw, Allan; Morris, Joan K; Boniface, Sadie; Tang, Jin-Ling; Milenkovic, Dusan (24 January 2018). "Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study report.
9.  Kerola, AM; Kauppi, MJ; Kerola, T; Nieminen, TV (October 2012). "How early in the course of rheumatoid arthritis does the excess cardiovascular risk appear?". Annals of the rheumatic diseases. 71 (10): 1606–15.  
10.  Kharade S.M, Rajmane M.A, Samudre P.A, Patil S.S. A Review: Etiology and Path physiology of Congestive Heart Failure. International Journal of Pharmaceutical and Phytopharmacological Research, 2014; 3(5): 352-356.
11.  Kontos, MC; Diercks, DB; Kirk, JD (Mar 2010). "Emergency department and office-based evaluation of patients with chest pain". Mayo Clinic Proceedings. 85 (3): 284–99.
12.  Kwak SM, Myung SK, Lee YJ, Seo HG (2012-04-09). "Efficacy of Omega-3 Fatty Acid Supplements (Eicosapentaenoic Acid and Docosahexaenoic Acid) in the Secondary Prevention of Cardiovascular Disease: A Meta-analysis of Randomized, Double-blind, Placebo-Controlled Trials". Archives of Internal Medicine. 172 (9): 686–94.
13.  Mendis, Shanthi  Puska, Pekka; Norrving, Bo (2011). Global atlas on cardiovascular disease prevention and control (PDF) (1st ed.). Geneva: World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization. pp. 3–18.  
14.  Ohman, EM (March 2016). "CLINICAL PRACTICE. Chronic Stable Angina". New England Journal of Medicine. 374 (12): 1167–76.
15.  Schocken DD, Ischemic heart diseases: A scientific statement from the American Heart Association. Circulation. 2015.
16.  Stergiopoulos K, Boden WE, Hartigan P, Mobius-Winkler S, Hambrecht R, Hueb W, Hardison RM, Abbott JD, Brown DL (2014). "Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials". JAMA Intern Med. 174 (2): 232–40.
17.  Walker C, Reamy BV (April 2009). "Diets for cardiovascular disease prevention: what is the evidence?". Am Fam Physician. 79 (7): 571–8.



Subscribe to Pharmatutor Alerts by Email